Celon Pharma (CLN.WA) Stock Price
Celon Pharma Price
Over the last 13 years Celon Pharma grew revenue by 13.6% annually, reaching 209.80 M PLN. Earnings per share have grown at 40.3% per year over the last 7 years. For Celon Pharma, the net margin of -37.8% is down versus -5.9% a few years ago. At today's price the dividend yield works out to roughly 0.42%. The consensus 12-month price target for Celon Pharma is 17.34 PLN, about 8.5% below where the stock trades today. Of 11 analysts, 1 rate the stock a buy — an overall Sell consensus.
Celon Pharma stock price
Celon Pharma business model & stock analysis
Frequently asked questions about Celon Pharma
Analysts currently set an average price target of 17.34 PLN for the Celon Pharma stock (median: 17.34 PLN), implying -8.5 % versus the latest price. The consensus is based on 11 analyst ratings.
11 analysts currently rate the Celon Pharma stock: 1 recommend buying, 4 holding and 6 selling. For 2026, analysts expect Celon Pharma to generate revenue of 265.42 M PLN and earnings per share of 1.47 PLN.
Converted at the current exchange rate, the Celon Pharma share trades at 4.32 EUR (18.96 PLN).
The Celon Pharma share (CLN.WA) is listed on 5 stock exchanges, including: London (0RKX.L), Frankfurt (8RP.F), München (8RP.MU).
The expected revenue of Celon Pharma is 265.42 M PLN. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Celon Pharma is 79.22 M PLN. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Celon Pharma is currently 12.89. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Celon Pharma stock.
The price-to-sales ratio (P/S) of Celon Pharma is currently 3.85. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Celon Pharma stock.
The Eulerpool Quality Score for Celon Pharma is 3/10.
The ISIN of Celon Pharma is PLCLNPH00015. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Celon Pharma is A2DJW6. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Celon Pharma is CLN.WA. The ticker symbol is used to trade Celon Pharma shares on the stock exchange.
Celon Pharma stock
Celon Pharma Peer Group
Celon Pharma Ticker
Celon Pharma FIGI
All fundamentals and in-depth analysis of Celon Pharma
Our stock analysis for Celon Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Celon Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.